Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Bridging anticoagulation may raise post-surgery bleeding risks.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

PRFM may help treat hair loss, especially in mild cases.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The SGAP flap effectively treats large sacral pressure sores with good results and minimal complications.

Hair transplant surgeries can be improved by preserving follicles in a special solution, and surgeries done at outpatient facilities are more profitable than those at hospitals.

Outpatient aesthetic and reconstructive surgeries are about equally profitable in Academic Health Centers and Ambulatory Surgery Centers when time is considered, but dedicated surgery centers are generally more profitable.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.